Search This Blog

Thursday, August 6, 2026

Iovance reviewed 2026 revenue guidance, citing strong Amtagvi demand as key driver

 

Iovance posts record Q2 2026 revenue of ~$99M, loss $47.3M, guides 2026 revenue to $350M-$370M

  • Q2 2026 gross margin reached 56%, accompanying record revenue of approximately $99 million.
  • Company reviewed 2026 revenue guidance, citing strong Amtagvi demand as a key driver.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)